Severe childhood psoriasis : need for safety and efficacy data on long-term treatment with biologics
| Errataetall: |
CommentOn: Br J Dermatol. 2019 Dec;181(6):1177-1189. - PMID 31017657 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:181 |
|---|---|
| Enthalten in: |
The British journal of dermatology - 181(2019), 6 vom: 19. Dez., Seite 1127-1128 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Belloni Fortina, A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adalimumab |
|---|
| Anmerkungen: |
Date Completed 03.06.2020 Date Revised 03.06.2020 published: Print-Electronic CommentOn: Br J Dermatol. 2019 Dec;181(6):1177-1189. - PMID 31017657 Citation Status MEDLINE |
|---|
| doi: |
10.1111/bjd.18362 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM300337973 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM300337973 | ||
| 003 | DE-627 | ||
| 005 | 20231225102314.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjd.18362 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1001.xml |
| 035 | |a (DE-627)NLM300337973 | ||
| 035 | |a (NLM)31423573 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Belloni Fortina, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Severe childhood psoriasis |b need for safety and efficacy data on long-term treatment with biologics |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.06.2020 | ||
| 500 | |a Date Revised 03.06.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Br J Dermatol. 2019 Dec;181(6):1177-1189. - PMID 31017657 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Biological Factors |2 NLM | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 650 | 7 | |a Adalimumab |2 NLM | |
| 650 | 7 | |a FYS6T7F842 |2 NLM | |
| 700 | 1 | |a Caroppo, F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The British journal of dermatology |d 1951 |g 181(2019), 6 vom: 19. Dez., Seite 1127-1128 |w (DE-627)NLM000000361 |x 1365-2133 |7 nnns |
| 773 | 1 | 8 | |g volume:181 |g year:2019 |g number:6 |g day:19 |g month:12 |g pages:1127-1128 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjd.18362 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 181 |j 2019 |e 6 |b 19 |c 12 |h 1127-1128 | ||